Your contracting with others to do work involving use or handling or raw asbestos or asbestos containing products ANSWER a - c See Preliminary Statement and General Objections Over the years many of answering defendant's refineries had installed thermal insulation products which contained some percentage of asbestos Many of these plants are not in the geographic area and defendant objects to producing information regarding those plants as not relevant nor will lead - to discoverable evidence Answering defendant was not in the business of marketing raw asbestos or asbestos containing thermal insulation products It is impracticable to identify all persons knowledgeable .

v>EPA United States E n viro n m en t Agency Emerging Contaminants - Perfluorooctane Sulfonate (PFOS) and Perfluorooctanoic Acid (PFOA) March 2014 United States Environmental Protection Agency jction An "emerging contaminant" is a chemical or material that is characterized by a perceived, potential, or real threat to human health or the environment or by a lack of published health standards.

That focus may be changing, however, with a warning sent by one of the country's leading lung disease experts.

Bondex objects to these Requests for Admissions and Interrogatories on the grounds that they are vague, ambiguous, overly broad, unduly burdensome, and seek information which is irrelevant and immaterial and which is not reasonably calculated to lead to the discovery of admissible evidence.

Within a few years the company had acquired pipelines, leases, storage tanks -- and was emerging as one of Ohio's leading suppliers of crude oil.

EUTurbines Reply to ECHA consultation on PFAS - impact of a potential PFAS restriction Executive Summary In this paper, EUTurbines elaborates further on the reasons that lead the turbine and steam power plant industry to ask for a derogation on the PFAS restriction.

UNITED STATES OF AMERICA Securities and Exchange Commission ATTESTATION I HEREBY ATTEST f^a{: Attached is a copy of, quarterly report on Form 10-0, for the quarterly period ended September 30, 2000, received in this Commission November 13, 2000, under the name The Quigley Corporation, File No. 0-21617, pursuant to the provisions of the Securities Exchange Act of 1934.

FILE NAME: Doubt Science (DBTS) DATE: 2007 DOC#: DBTS002 DOCUMENT DESCRIPTION: Egilman Journal Article from IJOEH - Against AntiHealth Epidemiology: Corporate Obstruction of Public Health Via Manipulation of Epidemiology Against Anti-health Epidemiology: Corporate Obstruction of Public Health via Manipulation of Epidemiology DAVID EGILMAN MD, MPH, SAMANTHA HOWE In response to several articles on corporate corruption of science that appeared earlier in this journal, a critic outlined an epistemological model based on an unsup ported assertion that epidemiologic evidence is always required to support cause-effect relationships.

Provision should be made for inputs relating to the type of PPE used, the mechanism/events leading to injury or disease, and the efficacy of PPE.

1 1 STATE OF INDIANA 2 COUNTY OF MARION 3 4 IN THE MARION SUPERIOR COURT 5 CIVIL DIVISION, ROOM 2 6 CAUSE NO. 49D02-9501-MI-0001-374 7 8 FREAL and MARY FRYE, 9 Plaintiff, 10 vs. 11 ACandS, INC., et al, 12 Defendants. 13 14 15 16 DEPOSITION OF: CARLO MARTINO 17 WEDNESDAY, MAY 9, 2001 18 19 20 21 22 ATLANTIC CITY COURT REPORTING COMPANY LLC 23 1125 Atlantic Avenue, Suite 416 24 Atlantic City, New Jersey 08401 25 609-345-8448 DUPLICATE FILE COPY F:\Desktop\martmodepo.doc Deposition of CARLO MARTINO, taken in the above-entitled matter before Phyllis A.

Chronic Obstructive Pulmonary Disease (COPD) is characterised by a progressive, irreversible, decline in lung function and includes chronic bronchitis and emphysema, both of which can lead to the development of airways obstruction that may lead to impairment of lung function, disability and death.

Chronic Obstructive Pulmonary Disease (COPD) is characterised by a progressive, irreversible, decline in lung function and includes chronic bronchitis and emphysema, both of which can lead to the development of airways obstruction that may lead to impairment of lung function, disability and death.

HISTORY OF THE M.V.S. by Melanie Low Electronic Copy by David W.

LIGHTFOOT, FRANKLIN & WHITE, LLC 9 The Clark Building 400 North 20th Street 10 Birmingham, Alabama 35203 11 12 13 14 15 16 17 18 19 20 21 22 23 REGIONAL REPORTING SERVICE, INC. 4 1 STIPULATIONS 2 IT IS STIPULATED AND AGREED, by 3 the parties, that the deposition of CRAIG R. 4 BRANCHFIELD may be taken before Janet F. 5 Russo, as Commissioner and Notary Public, 6 Alabama at Large, at Birmingham, Alabama, on 7 July 24, 2001, commencing at 10:00 a.in. 8 IT IS STIPULATED AND AGREED that the 9 signature to and reading of the deposition by 10 the witness is waived, the deposition to have 11 the same force and effect as if full 12 compliance were had with all laws and rules of 13 Court relating to the taking of depositions. 14 IT IS STIPULATED AND AGREED that it 15 shall not be necessary for any objections to 16 be made by counsel to any questions except as 17 to form or leading questions and that counsel 18 may make objections and assign grounds at the 19 time of trial or at the time said deposition 20 is offered in evidence or prior thereto. 21 IT IS STIPULATED AND AGREED that 22 notice of filing by the commissioner is 23 waived.

We do 2 various government work, doing abatement 3 planning for removal of asbestos or lead in 4 buildings, government buildings, schools.